These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22957435)

  • 1. Modulation of drug release from nanocarriers loaded with a poorly water soluble drug (flurbiprofen) comprising natural waxes.
    Baviskar DT; Amritkar AS; Chaudhari HS; Jain DK
    Pharmazie; 2012 Aug; 67(8):701-5. PubMed ID: 22957435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax.
    Kheradmandnia S; Vasheghani-Farahani E; Nosrati M; Atyabi F
    Nanomedicine; 2010 Dec; 6(6):753-9. PubMed ID: 20599527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
    Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
    Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery.
    Park KM; Kim CK
    Int J Pharm; 1999 Apr; 181(2):173-9. PubMed ID: 10370213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
    Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
    Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of flurbiprofen-loaded nanoparticles with a narrow size distribution using sucrose.
    Oh DH; Yan YD; Kim DW; Kim JO; Yong CS; Choi HG
    Drug Dev Ind Pharm; 2014 Feb; 40(2):172-7. PubMed ID: 23600652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
    Shinde UA; Joshi PN; Jain DD; Singh K
    Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent.
    Ranjha NM; Khan H; Naseem S
    J Mater Sci Mater Med; 2010 May; 21(5):1621-30. PubMed ID: 20217193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change.
    Oh DH; Park YJ; Kang JH; Yong CS; Choi HG
    Drug Deliv; 2011 Jan; 18(1):46-53. PubMed ID: 20726805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and Labrasol.
    Soliman MS; Khan MA
    Pharmazie; 2005 Apr; 60(4):288-93. PubMed ID: 15881610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease.
    Sareen R; Jain N; Dhar KL
    Curr Drug Deliv; 2013 Oct; 10(5):564-71. PubMed ID: 23360241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of binary solid lipid matrix of wax and triglyceride on lipid crystallinity, drug-lipid interaction and drug release of ibuprofen-loaded solid lipid nanoparticles (SLN) for dermal delivery.
    Chantaburanan T; Teeranachaideekul V; Chantasart D; Jintapattanakit A; Junyaprasert VB
    J Colloid Interface Sci; 2017 Oct; 504():247-256. PubMed ID: 28551519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
    Kawadkar J; Pathak A; Kishore R; Chauhan MK
    Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges.
    Orlu M; Cevher E; Araman A
    Int J Pharm; 2006 Aug; 318(1-2):103-17. PubMed ID: 16687222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles.
    Zhao X; Li W; Luo Q; Zhang X
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):61-7. PubMed ID: 23700219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.